Pharmaceutical Compositions Comprising Sorbitan Esters
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
1 Citation
62 Claims
-
1-40. -40. (canceled)
-
41. A method for treating schizophrenia in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
(a) 20-30 weight percent compound A-7; - View Dependent Claims (42, 43, 44)
-
45. A method for treating bipolar disorder in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
(a) 20-30 weight percent compound A-7; - View Dependent Claims (46, 47, 48)
-
49. A method for treating depression in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
(a) 20-30 weight percent compound A-7; - View Dependent Claims (50, 51, 52)
-
53. A method for treating anxiety, autism-related irritability, or acute mania in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising:
(a) 20-30 weight percent compound A-7; - View Dependent Claims (54, 55, 56, 57, 58, 59)
-
60. A pharmaceutical composition comprising:
(a) 20-30 weight percent compound A-7; - View Dependent Claims (61, 62)
Specification